期刊文献+

叶酸介导肿瘤靶向紫杉醇纳米粒冷冻干燥工艺及其表征 被引量:1

Characteristics of Freeze-dried Folate-decorated Paclitaxel-loaded Bovine Serum Albumin Nanoparticles
下载PDF
导出
摘要 目的:研究了叶酸介导紫杉醇白蛋白纳米粒的冻干工艺及其表征。方法:选用甘露醇、牛血清白蛋白及海藻糖三种冻干保护剂,以叶酸介导紫杉醇白蛋白纳米粒冻干前与复溶后聚集状态(平均粒径和多分散系数)、表观形态、稳定性系数fc及Zeta电位为指标,筛选冻干保护的合适浓度,并考察在适当浓度下纳米粒微观形态及复溶后8小时连续稳定性。结果:三种冻干保护剂在浓度不小于1%时起到保护作用。与无保护剂样品相比,冻干后紫杉醇纳米粒粒径更小,分布范围更窄,能够在水相中充分溶解,且在复溶后连续8小时内有良好的稳定性。结论:通过对叶酸介导紫杉醇白蛋白纳米粒冻干工艺及表征的研究,证明合适的冻干保护剂浓度条件下可以获得稳定的紫杉醇纳米粒冻干注射剂。 Objective:Aim of this study was to investigate folate - decorated paclltaxel - load bovine serum albumin nano- particles( PTX - FA - BSANPs) lyophilizing process and its characteristics. Methods: PTX - FA - BSANPs aggregation state (average particle size and polydispersity), the apparent trait and the Zeta potential as an indicator which screened the protective effect of various types and concentrations of lyoprotectant. Results:The concentration of mannitol, bovine serum albumin and trehalose was not less than 1% playing a protective role. PTX - FA - BSANPs compared with no lyprotectant had a smal- ler particle size and polydispersity. The samples can be sufficienfly dissolved in the aqueous phase, and has a better stability. Conclusion: A stable PTX - FA - BSANPs lyophilization could be obtained with appropriate concentration and lyoph- ilization conditions through screening freeze - drying process and its characteristics.
出处 《黑龙江医药》 CAS 2013年第1期15-19,共5页 Heilongjiang Medicine journal
基金 黑龙江省博士后科研启动金(LBH-Q11175) 中央高校基本科研业务费专项资金项目(DL11BB06)
关键词 纳米粒 冷冻干燥 稳定性 冻干保护剂 PTX - FA - BSANPs freeze - drying Stability lyoprotectant
  • 相关文献

参考文献21

  • 1魏晓慧,王伟,张钧寿.不含聚氧乙烯蓖麻油的紫杉醇静脉注射剂研究进展[J].中国医药工业杂志,2001,32(4):188-192. 被引量:14
  • 2Zhao D M, Zhao X H,ZU Y G,et al. Preparation, characterization, and in vitro targeted delivery of folate - decorated paclitaxel - loaded bovine serum albumin nanopartides [ J ]. int J Nanomedi- cine,2010,5:669 - 677.
  • 3Abdelwahed W, Degobert G, Stainmesse S ,et al. Freeze - drying of nanoparticles : formulation, process and storage considerations [ J ]. Adz Drug Deliv Rev 12006,58 (15) :1688 - 1713.
  • 4Pyne A, Chatterjee K, Suryanamyanan R, Solute crystallization in monnitol - glyeine systems - implications on protein stabilization in freeze - dried formulations [ J ]. Pharm. Sci. 2003,92,2272 - 2283.
  • 5Carpenter J F, Pikal M J, Chang B S,et al. Rational design of sta- ble lyophilized protein formulations: some practical advice [ J]. Pharm. Res. 1997,14,969 - 975.
  • 6Passot S, Fonseca F, Alarcon - Lorca M, etal. Physical characteri- sation of formulations for the development of two stable freeze - dried proteins during both dried and liquid storage [J].Phanm Biophanm 2005,60,335 -348.
  • 7Johnson B E, Kirchhoff C F, Caud H T. Mannito! - sucrose mix- tures - versatile formulations for protein lyophilization [ J ]. Pharm. Sci. 2002,91,914 -922.
  • 8孙东坡,胡一桥.蛋白质冷冻干燥制品中的保护剂及其保护机制[J].药学进展,2003,27(4):201-205. 被引量:55
  • 9Saez A,Guzma' n M, Molpeceres J, et al. Freze - drying of poly- capmlactone and poly ( D, L - lactic - glye.otic) nanoparticles in- duce minor particle size changes affecting the oral pharmacokinet- ics d loaded drugs[J]. Biophrm. 2000,50,379-387.
  • 10Chen C, Han D, Ca C, etal. An overview of liposome lyophiliza- tion and its future potential[ J]. ControH. Rel,. 2010,142,299 - 311.

二级参考文献45

  • 1王亚敏,石庭森,张艳红.抗癌新药紫杉醇的药剂学研究概况[J].中国医院药学杂志,1996,16(4):176-178. 被引量:5
  • 2阎家麒,童岩,王九一.紫杉醇脂质体的制备及其抑瘤作用的研究[J].药物生物技术,1996,3(3):154-157. 被引量:40
  • 3Rey L, May J C. Freeze-drying/lyophilization of pharmaceutical and biological products [ M]. New York: Marcel Dekker, Inc. , 2004:2-4.
  • 4Reinisalo M, Urtti A, Honkakoski P. Freeze-drying of cationic polymer DNA complexes enables their long-term storage and reverse transfection of post-mitotic cells[ J ]. Journal of Controlled Release, 2006, 110 (2) : 437- 443.
  • 5Heikal A, Box K, Rothnie A, et al. The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides [ J]. Cryobiology, 2009, 58 ( 1 ) : 37 - 44.
  • 6Anhorn M G, Mahler H C, Langer K. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients [ J]. International Journal of Pharmaceutics, 2008, 363 ( 1 - 2) : 162 - 169.
  • 7Frank F. Effective freeze-drying:a combination of physics, chemistry, engineering and economics [ C ]//Proceedings of the Institute of Refrigeration, 1994, 91: 32- 39.
  • 8Pikal M J. Use of laboratory data in freeze drying process design: heat and mass transfer coefficients and the computer simulation of freeze drying [J]. Journal of Parenteral Science and Technology, 1985, 39(3) : 115 - 138.
  • 9Carpenter J F, Pikal M J, Chang B S, et al. Rational design of stable lyophilized protein formulations: some practical advice [J]. Pharmaceutical Research, 1997, 14(8): 969 -975.
  • 10Duddu S P, Dal Monte P R. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody [ J]. Pharmaceutical Research, 1997, 14(5): 591 -595.

共引文献75

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部